These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 6098633)

  • 1. The interaction of [3H]PY 108-068 and of [3H]PN 200-110 with calcium channel binding sites in rat brain.
    Supavilai P; Karobath M
    J Neural Transm; 1984; 60(3-4):149-67. PubMed ID: 6098633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular approach to the calcium channel.
    Glossmann H; Ferry DR; Goll A; Linn T
    Adv Myocardiol; 1985; 5():41-76. PubMed ID: 2578683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High affinity specific [3H](+)PN 200-110 binding to dihydropyridine receptors associated with calcium channels in rat cerebral cortex and heart.
    Lee HR; Roeske WR; Yamamura HI
    Life Sci; 1984 Aug; 35(7):721-32. PubMed ID: 6088927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium antagonist binding sites in the rat brain: quantitative autoradiographic mapping using the 1,4-dihydropyridines [3H]PN 200-110 and [3H]PY 108-068.
    Cortés R; Supavilai P; Karobath M; Palacios JM
    J Neural Transm; 1984; 60(3-4):169-97. PubMed ID: 6241226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential labelling of putative skeletal muscle calcium channels by [3H]-nifedipine, [3H]-nitrendipine, [3H]-nimodipine and [3H]-PN 200 110.
    Ferry DR; Goll A; Glossmann H
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Jul; 323(3):276-7. PubMed ID: 6312337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective modulation by membrane potential of the interaction of some calcium entry blockers with calcium channels in rat mesenteric artery.
    Morel N; Godfraind T
    Br J Pharmacol; 1988 Sep; 95(1):252-8. PubMed ID: 2851351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purified calcium channels have three allosterically coupled drug receptors.
    Striessnig J; Goll A; Moosburger K; Glossmann H
    FEBS Lett; 1986 Mar; 197(1-2):204-10. PubMed ID: 2419161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection by verapamil and nifedipine against ischaemia-induced loss of [3H]-(+)-PN 200-110 binding sites in the rat heart.
    van Amsterdam FT; van Amsterdam-Magnoni MS; Haas M; Punt NC; Zaagsma J
    Naunyn Schmiedebergs Arch Pharmacol; 1990; 341(1-2):137-42. PubMed ID: 2156175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Voltage-dependent binding of 1,4-dihydropyridine Ca2+ channel antagonists and activators in cultured neonatal rat ventricular myocytes.
    Wei XY; Rutledge A; Triggle DJ
    Mol Pharmacol; 1989 Apr; 35(4):541-52. PubMed ID: 2539561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of ethanol on [3H]nitrendipine binding to calcium channels in brain membranes.
    Greenberg DA; Cooper EC
    Alcohol Clin Exp Res; 1984; 8(6):568-71. PubMed ID: 6097136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. (-)[3H]amlodipine binding to rat cardiac membranes.
    Nayler WG; Gu XH
    J Cardiovasc Pharmacol; 1991 Apr; 17(4):587-92. PubMed ID: 1711625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of specific bindings of nitrendipine and PN200-110 to various crude membranes: induction of irreversible bindings by UV irradiation.
    Ichida S; Fujisue T; Masada A; Oda Y; Matsuda N; Aonuma S
    J Biochem; 1989 May; 105(5):760-6. PubMed ID: 2526807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential-dependent allosteric modulation of 1,4-dihydropyridine binding by d-(cis)-diltiazem and (+/-)-verapamil in living cardiac cells.
    Porzig H; Becker C
    Mol Pharmacol; 1988 Aug; 34(2):172-9. PubMed ID: 2457793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allosteric modulation by diltiazem and verapamil of [3H]nitrendipine binding to calcium channel sites in rat brain.
    Schoemaker H; Boles RG; Roeske WR; Yamamura HI
    Proc West Pharmacol Soc; 1983; 26():219-24. PubMed ID: 6310626
    [No Abstract]   [Full Text] [Related]  

  • 15. (-)-[3H] desmethoxyverapamil labels multiple calcium channel modulator receptors in brain and skeletal muscle membranes: differentiation by temperature and dihydropyridines.
    Reynolds IJ; Snowman AM; Snyder SH
    J Pharmacol Exp Ther; 1986 Jun; 237(3):731-8. PubMed ID: 3012067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SR 33557, a novel calcium entry blocker. II. Interactions with 1,4-dihydropyridine, phenylalkylamine and benzothiazepine binding sites in rat heart sarcolemmal membranes.
    Nokin P; Clinet M; Beaufort P; Meysmans L; Laruel R; Chatelain P
    J Pharmacol Exp Ther; 1990 Nov; 255(2):600-7. PubMed ID: 2147036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium channel receptor sites for (+)-[3H]PN 200-110 in coronary artery.
    Yamada S; Kimura R; Harada Y; Nakayama K
    J Pharmacol Exp Ther; 1990 Jan; 252(1):327-32. PubMed ID: 2153804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel high affinity class of Ca2+ channel blockers.
    Qar J; Barhanin J; Romey G; Henning R; Lerch U; Oekonomopulos R; Urbach H; Lazdunski M
    Mol Pharmacol; 1988 Apr; 33(4):363-9. PubMed ID: 2965787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversible dihydropyridine isothiocyanate binding to brain calcium channels.
    Greenberg DA; Cooper EC; Carpenter CL
    J Neurochem; 1985 Jan; 44(1):319-21. PubMed ID: 2578060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the effects of omega-conotoxin GVIA on the responses of voltage-sensitive calcium channels.
    Keith RA; Mangano TJ; Pacheco MA; Salama AI
    J Auton Pharmacol; 1989 Aug; 9(4):243-52. PubMed ID: 2570074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.